Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1549 (LINC01549) is a human long non-coding RNA located in an intergenic region of chromosome 21, also annotated as C21orf37. Like other lincRNAs, it is transcribed as a long RNA molecule (>200 nucleotides) that does not overlap protein-coding genes and is believed not to encode protein. LincRNAs can regulate transcription, remodel chromatin, and influence gene expression in tissue- and context-specific ways, but the specific function, interactions, and clinical significance of LINC01549 remain uncharacterized in the scientific literature. Some lincRNAs have emerging roles in disease, including as oncogenes or tumor suppressors, but no such annotation currently exists for LINC01549[1][5].
Not applicable, as there are no drugs or established inhibitory strategies for this RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1549 (LINC01549).